181 related articles for article (PubMed ID: 37951051)
1. Masculinizing hormone therapy effect on breast tissue: Changes in estrogen and androgen receptors in transgender female-to-male mastectomies.
Chaum M; Grossi S; Chen J; Hu V; Ray E; Giuliano A; Bose S
Breast; 2023 Dec; 72():103596. PubMed ID: 37951051
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer in transgender female-to-male individuals: A case report of androgen receptor-positive breast cancer.
Fundytus A; Saad N; Logie N; Roldan Urgoiti G
Breast J; 2020 May; 26(5):1007-1012. PubMed ID: 31749246
[TBL] [Abstract][Full Text] [Related]
3. Histopathologic Features of Breast Tissue From Transgender Men and Their Associations With Androgen Therapy.
Wolters EA; Rabe KE; Siegel L; Butts J; Klein ME
Am J Clin Pathol; 2023 Jan; 159(1):43-52. PubMed ID: 36469057
[TBL] [Abstract][Full Text] [Related]
4. Pathologic Evaluation of Breast Tissue From Transmasculine Individuals Undergoing Gender-Affirming Chest Masculinization.
Hernandez A; Schwartz CJ; Warfield D; Thomas KM; Bluebond-Langner R; Ozerdem U; Darvishian F
Arch Pathol Lab Med; 2020 Jul; 144(7):888-893. PubMed ID: 31816268
[TBL] [Abstract][Full Text] [Related]
5. The Incidence of Breast Cancer After Gender-Affirming Mastectomy in Transmen.
Parmeshwar N; Song S; Alcon A; Kim EA
Ann Plast Surg; 2022 May; 88(4 Suppl 4):S332-S336. PubMed ID: 35180758
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological findings in female-to-male gender-affirming breast surgery.
East EG; Gast KM; Kuzon WM; Roberts E; Zhao L; Jorns JM
Histopathology; 2017 Dec; 71(6):859-865. PubMed ID: 28657118
[TBL] [Abstract][Full Text] [Related]
7. The role of androgens in transgender medicine.
Dimakopoulou A; Millar OD; Moschonas D; Jayasena CN
Best Pract Res Clin Endocrinol Metab; 2022 Sep; 36(5):101617. PubMed ID: 35120800
[TBL] [Abstract][Full Text] [Related]
8. Androgen receptors and serum testosterone levels identify different subsets of postmenopausal breast cancers.
Secreto G; Venturelli E; Meneghini E; Carcangiu ML; Paolini B; Agresti R; Pellitteri C; Berrino F; Gion M; Cogliati P; Saragò G; Micheli A
BMC Cancer; 2012 Dec; 12():599. PubMed ID: 23241075
[TBL] [Abstract][Full Text] [Related]
9. Androgen metabolite-dependent growth of hormone receptor-positive breast cancer as a possible aromatase inhibitor-resistance mechanism.
Hanamura T; Niwa T; Nishikawa S; Konno H; Gohno T; Tazawa C; Kobayashi Y; Kurosumi M; Takei H; Yamaguchi Y; Ito K; Hayashi S
Breast Cancer Res Treat; 2013 Jun; 139(3):731-40. PubMed ID: 23780684
[TBL] [Abstract][Full Text] [Related]
10. Testosterone therapy and breast histopathological features in transgender individuals.
Baker GM; Guzman-Arocho YD; Bret-Mounet VC; Torous VF; Schnitt SJ; Tobias AM; Bartlett RA; Fein-Zachary VJ; Collins LC; Wulf GM; Heng YJ
Mod Pathol; 2021 Jan; 34(1):85-94. PubMed ID: 32939016
[TBL] [Abstract][Full Text] [Related]
11. Androgen receptor expression in a Sri Lankan patient cohort with early breast carcinoma.
Wijesinghe HD; Wijesinghe GK; Mansoor Z; Vigneshwara S; Fernando J; Gunasekera D; Lokuhetty MDS
BMC Womens Health; 2020 Sep; 20(1):206. PubMed ID: 32928183
[TBL] [Abstract][Full Text] [Related]
12. The Impact of Exogenous Testosterone on Breast Cancer Risk in Transmasculine Individuals.
Gurrala RR; Kumar T; Yoo A; Mundinger GS; Womac DJ; Lau FH
Ann Plast Surg; 2023 Jan; 90(1):96-105. PubMed ID: 36534108
[TBL] [Abstract][Full Text] [Related]
13. Oncologic Considerations for Safe Gender-Affirming Mastectomy: Preoperative Imaging, Pathologic Evaluation, Counseling, and Long-Term Screening.
Salibian AA; Axelrod DM; Smith JA; Fischer BA; Agarwal C; Bluebond-Langner R
Plast Reconstr Surg; 2021 Feb; 147(2):213e-221e. PubMed ID: 33565823
[TBL] [Abstract][Full Text] [Related]
14. [Dual effects of androgens on mammary gland].
Brettes JP; Mathelin C
Bull Cancer; 2008 May; 95(5):495-502. PubMed ID: 18541513
[TBL] [Abstract][Full Text] [Related]
15. Prostate Cancer in Male-to-Female Transgender Individuals: Histopathologic Findings and Association With Gender-affirming Hormonal Therapy.
Baraban E; Ding CC; White M; Vohra P; Simko J; Boyle K; Guo C; Zhang M; Dobs A; Ketheeswaran S; Liang F; Epstein JI
Am J Surg Pathol; 2022 Dec; 46(12):1650-1658. PubMed ID: 36006769
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical study of androgen receptors in breast carcinoma. Evidence of their frequent expression in lobular carcinoma.
Riva C; Dainese E; Caprara G; Rocca PC; Massarelli G; Tot T; Capella C; Eusebi V
Virchows Arch; 2005 Oct; 447(4):695-700. PubMed ID: 16075292
[TBL] [Abstract][Full Text] [Related]
17. Ovarian, breast, and metabolic changes induced by androgen treatment in transgender men.
Pirtea P; Ayoubi JM; Desmedt S; T'Sjoen G
Fertil Steril; 2021 Oct; 116(4):936-942. PubMed ID: 34481638
[TBL] [Abstract][Full Text] [Related]
18. Apocrine ductal carcinoma in situ associated with testosterone therapy in a transgender individual.
Mingrino J; Wang Y
Breast J; 2021 May; 27(5):475-477. PubMed ID: 33547745
[TBL] [Abstract][Full Text] [Related]
19. Pre-Menopausal Women With Breast Cancers Having High AR/ER Ratios in the Context of Higher Circulating Testosterone Tend to Have Poorer Outcomes.
Rajarajan S; Korlimarla A; Alexander A; Anupama CE; Ramesh R; Srinath BS; Sridhar TS; Prabhu JS
Front Endocrinol (Lausanne); 2021; 12():679756. PubMed ID: 34234742
[TBL] [Abstract][Full Text] [Related]
20. Role of Androgens in Female Genitourinary Tissue Structure and Function: Implications in the Genitourinary Syndrome of Menopause.
Traish AM; Vignozzi L; Simon JA; Goldstein I; Kim NN
Sex Med Rev; 2018 Oct; 6(4):558-571. PubMed ID: 29631981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
